ALPS Advisors’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$674K Buy
26,948
+3,401
+14% +$95.8K ﹤0.01% 649
2025
Q4
$741K Buy
23,547
+1,024
+5% +$34K ﹤0.01% 649
2025
Q3
$804K Buy
22,523
+8,854
+65% +$404K ﹤0.01% 601
2025
Q2
$787K Sell
13,669
-1,159
-8% -$65.5K ﹤0.01% 573
2025
Q1
$864K Buy
14,828
+4,353
+42% +$297K 0.01% 500
2024
Q4
$843K Sell
10,475
-692
-6% -$59.1K 0.01% 526
2024
Q3
$895K Sell
11,167
-3,610
-24% -$256K 0.01% 526
2024
Q2
$903K Sell
14,777
-6,161
-29% -$366K 0.01% 487
2024
Q1
$1.03M Sell
20,938
-5,060
-19% -$241K 0.01% 474
2023
Q4
$1.09M Sell
25,998
-2,528
-9% -$86.1K 0.01% 455
2023
Q3
$936K Sell
28,526
-4,017
-12% -$137K 0.01% 478
2023
Q2
$1.15M Sell
32,543
-3,228
-9% -$107K 0.01% 448
2023
Q1
$1.02M Buy
35,771
+9,513
+36% +$336K 0.01% 467
2022
Q4
$1.09M Buy
26,258
+758
+3% +$32.5K 0.01% 452
2022
Q3
$1.06M Buy
+25,500
New +$1.02M 0.01% 455

Other funds holding PRCT